These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 23695082)

  • 1. Stability and trapping of magnetic resonance imaging contrast agents during high-intensity focused ultrasound ablation therapy.
    Hijnen NM; Elevelt A; Grüll H
    Invest Radiol; 2013 Jul; 48(7):517-24. PubMed ID: 23695082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the ablation region after magnetic resonance-guided high-intensity focused ultrasound ablation in a Vx2 tumor model.
    Wijlemans JW; Deckers R; van den Bosch MA; Seinstra BA; van Stralen M; van Diest PJ; Moonen CT; Bartels LW
    Invest Radiol; 2013 Jun; 48(6):381-6. PubMed ID: 23399810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance guided high-intensity focused ultrasound mediated hyperthermia improves the intratumoral distribution of temperature-sensitive liposomal doxorubicin.
    de Smet M; Hijnen NM; Langereis S; Elevelt A; Heijman E; Dubois L; Lambin P; Grüll H
    Invest Radiol; 2013 Jun; 48(6):395-405. PubMed ID: 23399809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleaved Mapping of Temperature and Longitudinal Relaxation Rate to Monitor Drug Delivery During Magnetic Resonance-Guided High-Intensity Focused Ultrasound-Induced Hyperthermia.
    Kneepkens E; Heijman E; Keupp J; Weiss S; Nicolay K; Grüll H
    Invest Radiol; 2017 Oct; 52(10):620-630. PubMed ID: 28598900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinically feasible treatment protocol for magnetic resonance-guided high-intensity focused ultrasound ablation in the liver.
    Wijlemans JW; de Greef M; Schubert G; Bartels LW; Moonen CT; van den Bosch MA; Ries M
    Invest Radiol; 2015 Jan; 50(1):24-31. PubMed ID: 25198833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour hyperthermia and ablation in rats using a clinical MR-HIFU system equipped with a dedicated small animal set-up.
    Hijnen NM; Heijman E; Köhler MO; Ylihautala M; Ehnholm GJ; Simonetti AW; Grüll H
    Int J Hyperthermia; 2012; 28(2):141-55. PubMed ID: 22335228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive magnetic resonance imaging follow-up of sono-sensitive liposome tumor delivery and controlled release after high-intensity focused ultrasound.
    Fowler RA; Fossheim SL; Mestas JL; Ngo J; Canet-Soulas E; Lafon C
    Ultrasound Med Biol; 2013 Dec; 39(12):2342-50. PubMed ID: 24246245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus.
    Zhang L; Chen WZ; Liu YJ; Hu X; Zhou K; Chen L; Peng S; Zhu H; Zou HL; Bai J; Wang ZB
    Eur J Radiol; 2010 Feb; 73(2):396-403. PubMed ID: 19108974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
    Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
    Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance-guided shielding of prefocal acoustic obstacles in focused ultrasound therapy: application to intercostal ablation in liver.
    Salomir R; Petrusca L; Auboiroux V; Muller A; Vargas MI; Morel DR; Goget T; Breguet R; Terraz S; Hopple J; Montet X; Becker CD; Viallon M
    Invest Radiol; 2013 Jun; 48(6):366-80. PubMed ID: 23344514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
    Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
    Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of Magnetic Resonance Imaging-guided High-Intensity Focused Ultrasound ablation on human cadaver breast tissue.
    Merckel LG; Deckers R; Baron P; Bleys RL; van Diest PJ; Moonen CT; Mali WP; van den Bosch MA; Bartels LW
    Eur J Pharmacol; 2013 Oct; 717(1-3):21-30. PubMed ID: 23583321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric MR-HIFU ablation of uterine fibroids: role of treatment cell size in the improvement of energy efficiency.
    Kim YS; Keserci B; Partanen A; Rhim H; Lim HK; Park MJ; Köhler MO
    Eur J Radiol; 2012 Nov; 81(11):3652-9. PubMed ID: 21959213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amide proton transfer imaging of high intensity focused ultrasound-treated tumor tissue.
    Hectors SJ; Jacobs I; Strijkers GJ; Nicolay K
    Magn Reson Med; 2014 Oct; 72(4):1113-22. PubMed ID: 24154945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR thermometry analysis of sonication accuracy and safety margin of volumetric MR imaging-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids.
    Kim YS; Trillaud H; Rhim H; Lim HK; Mali W; Voogt M; Barkhausen J; Eckey T; Köhler MO; Keserci B; Mougenot C; Sokka SD; Soini J; Nieminen HJ
    Radiology; 2012 Nov; 265(2):627-37. PubMed ID: 23012465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1 ρ mapping for the evaluation of high intensity focused ultrasound tumor treatment.
    Hectors SJ; Moonen RP; Strijkers GJ; Nicolay K
    Magn Reson Med; 2015 Apr; 73(4):1593-601. PubMed ID: 24753285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice.
    Ye J; Xu YK; Liu X; Lü GS
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):139-43. PubMed ID: 16503514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.